EyePoint Pharmaceuticals, Inc. (EYPT) vs Fulcrum Therapeutics, Inc. (FULC)
A side-by-side comparison of EyePoint Pharmaceuticals, Inc. and Fulcrum Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EYPT
EyePoint Pharmaceuticals, Inc.
$3.26HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
FULC
Fulcrum Therapeutics, Inc.
$3.72HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
Total return — EYPT vs FULC
growth of $100 · dividends reinvested · last 7yEYPT -78.6% (-19.8%/yr)FULC -72.5% (-16.8%/yr)FULC compounded faster over this window
EYPT FULC
EYPT vs FULC: by the numbers
- •FULC is the larger company ($283M vs $273M market cap).
- •Both run net losses; FULC's is the smaller (0.00% vs -10994.73% net margin).
Metrics side by side
Valuation
| Metric | EYPT | FULC |
|---|---|---|
| P/S ratio | 97.85 | N/A |
| P/B ratio | 1.64 | 0.91 |
Profitability
| Metric | EYPT | FULC |
|---|---|---|
| Gross margin | 93.41% | 0.00% |
| Operating margin | -775.98% | 0.00% |
| Net margin | -10994.73% | 0.00% |
| ROE | -184.27% | -27.36% |
| ROIC | -170.19% | -27.62% |
Growth (annualized)
| Metric | EYPT | FULC |
|---|---|---|
| Revenue CAGR (5Y) | -41.05% | N/A |
| Total return CAGR (5Y) | -21.68% | -31.70% |
Frequently asked
- How have EYPT and FULC total returns compared?
- Over the past 5 years, EYPT delivered -21.68% and FULC delivered -31.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.